A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery

Artificial Organs

Volumn 21, Issue 5, 1997, Pages 405-408

  Scavini, Marina ^a   Hammarberg, Bjorn ^b   Dosio, Flaviano ^a   Torri, Michiela ^a   Petrella, Giovanna ^a   Galimberti, Gabriella ^a   Vai, Silvia ^a   Fazio, Ferruccio ^a   Pozza, Guido ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Siemens Elema AB   (Sweden)

Author keywords

implantable insulin pumps; intraperitoneal insulin delivery; Technetium 99m imaging

Indexed keywords

CATHETERS; INSULIN; PUMPS;

IMPLANTABLE DEVICES; IMPLANTABLE INSULIN PUMP; INSULIN DELIVERY; INSULIN PUMPS; INSULIN THERAPY; INTRAPERITONEAL; INTRAPERITONEAL INSULIN DELIVERY; TECHNETIUM 99M IMAGING; TECHNETIUM-99M; WHOLE LENGTHS;

PATENTS AND INVENTIONS;

HUMAN INSULIN; INSULIN; TECHNETIUM 99M;

ARTICLE; CATHETER; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MINIPUMP; PRIORITY JOURNAL;

EID: 0030960227     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Selam JL, Micossi P, Dunn FL, Nathan DM, for Implantable Insulin Pump Trial Study Group. Clinical trial of programmable implantable insulin pump for type 1 diabetes. Diabetes Care 1992;15:877-85.
2. Hanaire-Broutin H, Broussolle C, Jeandidier N, Renard E, Guerci B, Haardt MJ, Lassmann-Vague V. for EVADIAC Study Group. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. Diabetes Care 1995;18:388-92.
3. Point Study II Group. Multicentre trial of a programmable implantable insulin pump in type I diabetes. Int J Artif Organs 1995;18:322-5.
4. Scavini M, Galli L, Sanford R, Eaton RP, Charles AM, Dunn FL on behalf of Implantable Insulin Pump Trial Study Group. Catheter survival during long-term insulin therapy with an implanted programmable pump. Diabetes Cure (in press).
5. Bousquet-Rouaud R, Castex F, Costalat G, Bastide M, Hedon B, Bouanani M, Jouvert S, Mirouze J. Factors involved in catheter obstruction during long-term peritoneal insulin infusion. Diabetes Care 1993;16:801-5.
6. Renard E, Baldet P, Picot MC, Jacques-Apostol D, Lauton D, Costalat G, Bringer J, Jaffiol J. Catheter complications associated with implantable systems for peritoneal insulin delivery. Diabetes Care 1995;18:300-6.
7. Scavini M, Reich S, Eaton RP, Charles MA, Dunn FL on behalf of Implantable Insulin Pump Trial Study Group. Use of an integrated sideport for diagnosis and management of decreased flow rates in a programmable implanted insulin delivery system. Artif Organs 20:992-4, 1996.
8. Grau U. Chemical stability of insulin in a delivery system environment. Diabetologia 1985;28:458-63.
9. Massey H. Development of insulin formulations lor mechanical delivery systems. ASAIO Trans 1986;4:653-5.
10. Olsen CL, Turner DS, Iravani M, Waxman K, Selam JL, Charles MA. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices. Diabetes Care 1995;18:70-6.
11. Haardt MJ, Behar A, Bouhladour H, Dorange C, Bethoux JP, Slama G, Selam JL. A noninvasive technique for identifying the mechanism of flow blockade in implantable insulin pumps. Horm Metab Res 1995;27:49.